Mediplantex National Pharmaceutical JSC (HNX:MED)
Vietnam flag Vietnam · Delayed Price · Currency is VND
18,400
0.00 (0.00%)
At close: May 13, 2026

HNX:MED Cash Flow Statement

Millions VND. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Net Income
24,01115,83315,24711,7446,3663,747
Depreciation & Amortization
6,8437,1697,9168,44410,0209,536
Other Amortization
5.577.43----
Loss (Gain) From Sale of Assets
-465.31--773.89-6,395-3,782-3,902
Other Operating Activities
1,5721,5722,015-1,9361,683-2,016
Change in Accounts Receivable
18,45327,76023,26137,5082,06358,829
Change in Inventory
8,306-5,67015,425-1,583-14,6644,843
Change in Accounts Payable
-23,756-51,176-16,803-95,35126,049-6,766
Change in Other Net Operating Assets
-16,863-873.161,3683,660-1,503-2,160
Operating Cash Flow
18,106-5,37747,653-43,90826,23162,110
Operating Cash Flow Growth
-----57.77%-30.49%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Capital Expenditures
-4,960-9,767-9,979-40,594-117,270-54,364
Sale of Property, Plant & Equipment
669.78--43.64240.21992.27
Investment in Securities
5,3005,3008,00072,400-44,0006,000
Other Investing Activities
-4,330510.861,1217,2043,3543,479
Investing Cash Flow
-6,321-3,956-858.4239,054-157,676-43,893

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Short-Term Debt Issued
-133,282157,753193,594205,142180,305
Total Debt Issued
124,166133,282157,753193,594205,142180,305
Short-Term Debt Repaid
--127,155-194,430-219,966-182,973-192,316
Total Debt Repaid
-120,225-127,155-194,430-219,966-182,973-192,316
Net Debt Issued (Repaid)
3,9416,127-36,676-26,37222,168-12,012
Issuance of Common Stock
----153,104-
Common Dividends Paid
-14,997-14,997-11,021-6,426-8,816-13,281
Financing Cash Flow
-19,474-8,870-47,697-32,799166,456-25,293

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-7.45-7.45-19.532.9-28.96-
Net Cash Flow
-7,696-18,210-922.47-37,65034,983-7,076

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Free Cash Flow
13,146-15,14437,674-84,502-91,0397,746
Free Cash Flow Growth
------87.20%
Free Cash Flow Margin
4.51%-4.13%8.50%-20.98%-22.70%2.25%
Free Cash Flow Per Share
1059.15-1220.283035.74-6809.19-9696.321234.13
Levered Free Cash Flow
-9,902-18,42729,827-101,170-115,88114,442
Unlevered Free Cash Flow
-8,711-16,98032,195-97,798-112,75416,703

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Jan '25 Jan '24 Dec '22 Dec '21
Cash Interest Paid
3,3332,3113,8165,4324,9533,643
Cash Income Tax Paid
6,1263,3993,8744,719272.582,383
Change in Working Capital
-13,860-29,95923,250-55,76511,94554,746